Skip to main content

Finance & Markets

Wall Street's Bull Case for Bristol Myers Squibb Is Getting Louder

The company's strong pipeline and newer approved drugs should be enough to allay patent expiration concerns.

fool.com ·1d ago

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Strategy Is Up 53% in the Past Month. Here's the Bull and Bear Case for One of Wall Street's Most Polarizing Stocks. fool.com
Wall Street's Bull Case for Bristol Myers Squibb Is Getting Louder nasdaq.com

Read the original at fool.com →

More in Finance & Markets

Billionaire Bill Ackman Has 13% of Pershing Square Capital Management's $19 Billion Hedge Fund in 1 Stock That's 31% Below Its 52-Week High

Key PointsCurrently the portfolio's single biggest holding, the Uber stake was initiated in January 2025.

1d ago ·nasdaq.com

Why You Should Avoid Palantir and Buy These 2 Defense Stocks Instead

Palantir is in the AI defense spotlight, but a pair of hardware-focused rivals may offer a steadier way to play the same trend.

1d ago ·fool.com

Trump’s softer China strategy puts markets on alert before Xi visit

1d ago ·seekingalpha.com

Midterm voters are overwhelmingly worried about the national debt. But only small fixes are expected this year.

Watchdog groups say midterm voters feel that “something’s wrong.”

1d ago ·marketwatch.com

Midterm voters are overwhelmingly worried about the national debt. But only small fixes are expected this year.

Watchdog groups say midterm voters feel that “something’s wrong.”

1d ago ·marketwatch.com

Volvo names Klaus Zellmer as next CEO amid turnaround push

1d ago ·seekingalpha.com

More from Sunday 20 September →